Australia’s Telix Pharma agrees to buy Germany’s ITM Isotope for about $1.65 billion

Australia’s Telix Pharma agrees to buy Germany’s ITM Isotope for about $1.65 billion

Sept 21 (Reuters) - Australia's Telix Pharmaceuticals ​said ‌on Monday it has ‌agreed ​to ⁠acquire Germany-based ⁠ITM Isotope Technologies Munich SE for ​about $1.65 billion ⁠on ⁠a ​cash- and ​debt-free basis. After adjustments, ‌ITM shareholders are e...

Radiopharma companies merge after one receives surprise FDA rejection

ITM Isotope Technologies Munich SE and Telix Pharmaceuticals, two leading companies in the burgeoning radiopharmaceuticals field, are merging.

Telix Pharmaceuticals: ITM merger builds a sector leader

Telix Pharmaceuticals Ltd (ASX: TLX) share price moves as the company announces a major merger with ITM, set to boost its revenue, pipeline, and global supply chain.

Telix Pharmaceuticals to buy ITM Isotope for $1.6B

Australian company Telix Pharmaceuticals Ltd. announced on Monday that it is acquiring biotech firm ITM Isotope Technologies Munich SE for $1.6 billion in 105.8 million Telix shares. Telix also commit...

Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse - Telix Pharmaceuticals Limited

Telix today announces it has signed a strategic agreement to combine with ITM Isotope Technologies Munich SE (“ITM”), a global leader in radioisotope production and radiopharmaceutical development.